-
Representing Companies and Investors Through All Stages of Growth
TJ advises entrepreneurs on formation, equity structures, financing transactions, and day-to-day corporate governance while also representing a broad range of investors.
-
Entrepreneurial and Operational Expertise
Prior to law school, TJ led product operations and business development at multiple venture-backed start-ups, including one acquired by a NYSE-listed company, giving her a hands-on understanding of the challenges and opportunities her clients face.
-
Cross-Border Deal Experience
TJ has extensive experience working with non-U.S. companies and investors seeking to relocate to, invest in, or raise capital in the U.S. Early in her career, TJ spent time in Asia. She also speaks fluent Mandarin Chinese.
TJ Tingjie Li is a corporate and securities law attorney in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where she advises companies through all stages of growth. She partners closely with entrepreneurs, providing strategic counseling on financing transactions and other day-to-day corporate governance matters. TJ also has significant experience advising investors at various sizes and stages of investment.
Before joining Wilson Sonsini, TJ was a foreign legal consultant at another leading international firm, where she handled complex transactions and regulatory matters. She also led product operations and business development initiatives at multiple startups, including one that was acquired by a NYSE-listed company.
While pursuing her J.D.-M.B.A. at Northwestern's Pritzker School of Law and Kellogg School of Management, TJ worked as a summer associate in Goldman Sachs’ Investment Management Division in San Francisco. She also supported Twilio’s legal department as an in-house legal intern at its San Francisco office.
TJ has worked in the firm’s Shanghai office, advising on cross-border venture capital, private equity, and capital markets transactions. She speaks fluent Mandarin and leverages her international experience to assist clients navigating cross-border deals and global market expansion.
TJ Tingjie Li is a corporate and securities law attorney in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where she advises companies through all stages of growth. She partners closely with entrepreneurs, providing strategic counseling on financing transactions and other day-to-day corporate governance matters. TJ also has significant experience advising investors at various sizes and stages of investment.
Before joining Wilson Sonsini, TJ was a foreign legal consultant at another leading international firm, where she handled complex transactions and regulatory matters. She also led product operations and business development initiatives at multiple startups, including one that was acquired by a NYSE-listed company.
While pursuing her J.D.-M.B.A. at Northwestern's Pritzker School of Law and Kellogg School of Management, TJ worked as a summer associate in Goldman Sachs’ Investment Management Division in San Francisco. She also supported Twilio’s legal department as an in-house legal intern at its San Francisco office.
TJ has worked in the firm’s Shanghai office, advising on cross-border venture capital, private equity, and capital markets transactions. She speaks fluent Mandarin and leverages her international experience to assist clients navigating cross-border deals and global market expansion.
- J.D., Northwestern Pritzker School of Law
- M.B.A., Northwestern Kellogg School of Management
- LL.B., Tsinghua University
- Leadership Advancement Program Fellow, National Asian Pacific American Bar Association, 2024-2025
- State Bar of California
- Qualified in People's Republic of China
- J.D., Northwestern Pritzker School of Law
- M.B.A., Northwestern Kellogg School of Management
- LL.B., Tsinghua University
- Leadership Advancement Program Fellow, National Asian Pacific American Bar Association, 2024-2025
- State Bar of California
- Qualified in People's Republic of China
Select company representations include:
- Represented project44 in its $240 million Series F financing, $180 million secondary financing and $80 million of strategic financing.
- Represented AliveCor in its Series F financing.
- Represented Vectra AI in its financings and corporate governance matters.
- Represented Insilico Medicine in its $255 million Series C financing.
- Represented Wuxi Diagnostic in its $150 million Series B financing.
- Represented BrightPlan in its Series B financing and note financing.
- Represented Percipient.ai in its Series C-1 financing.
- Represented Bryj in its Series C financing.
- Represented Axbio in its Series B financing.
- Represented On Your Six Distillery in its Series A financing.
- Represented Smelt Technologies in its Series A financing.
- Represented Megarobo Technologies in its investment of PGenAxy.
- Represented Bryte in its various note financings.
- Represented L-Charge in its Series A financing.
- Represented Project Vesta, PBC in its Series A financing.
- Represented Nova Credit Inc. in its Series B financing.
- Represented Mirvie in its Series A-1 financing.
- Represented Drop Water in its Series A financing.
Select investor representations include:
- Represented Sequoia Capital in its investment in Tim Hortons China.
- Represented Sequoia Capital in its investment in SprintRay.
- Represented Temasek in connection with its Series D investment in BlueVoyant.
- Represented Temasek in connection with its Series D investment in Twin Health.
- Represented Temasek in connection with its Series C3 investment in Provivi.
- Represented Venrock in its Series A investment in Viralogic Therapeutics.
- Represented Venrock in its Series A-3 investment in Candid Care.
- Represented RTW Investments in its Series B investment in Oricell.
- Represented Siemens Financial Services in its Series B-2 financing in 80 Acres.
- Represented Siemens Financial Services in its investment in KORE Power.
- Represented Pangaea Ventures in its Series B investment in Sun Genomics.
- Represented Boyu Capital in connection with its $104 million share purchase in Lifestyles Healthcare.
- Represented Boyu Capital in connection with its $100 million Series F investment in Huolala Global (Lalamove).
- Jointly represented Boyu Capital, Sequoia Capital, Matrix Partners and Wuxi AppTec in its $150 million Series A investment in D3 Bio.
- Represented Boyu Capital in connection with its Series C investment in 2Health Biosciences.
- Represented Boyu Capital in connection with its private equity investment in J&T Express.
- Represented Boyu Capital in connection with its Series B investment in Hongene Biotech.
- Represented Boyu Capital in connection with its private equity investment in Genki Forest.
- Represented Wuxi AppTec in its Series A investment in Simcha Therapeutics.
- Represented Catchlight Capital Partners in its various investments.
M&A and Capital Market Transactions*
- Represented Splunk in its acquisition of TwinWave Security.
- Represented Caption Health in acquisition by GE Healthcare.
- Represented Ji Xing Pharmaceuticals on Acquisition of BIIB131 from Biogen and Strategic Collaborations with TMS.
- Represented SK Growth Opportunities Corporation in $7.3 billion business combination with Webull Corporation.
- Represented GotIt! in its spin-off transaction for its artificial intelligence business.
- Represented Alibaba Group (BABA) in its $25 billion IPO and its listing in the NYSE.
- Represented the Stephen A. Schwarzman Education Foundation in connection with the creation of a $300 million scholarship fund for study at Tsinghua University in Beijing and the creation of Schwarzman College at the University.
- Represented Danone Asia Pte. Ltd. in connection with the formation of joint ventures with Inner Mongolia Mengniu (Group) Co., Ltd. for chilled yoghurt and related products in China.
* Includes matters handled prior to joining Wilson Sonsini.
Select company representations include:
- Represented project44 in its $240 million Series F financing, $180 million secondary financing and $80 million of strategic financing.
- Represented AliveCor in its Series F financing.
- Represented Vectra AI in its financings and corporate governance matters.
- Represented Insilico Medicine in its $255 million Series C financing.
- Represented Wuxi Diagnostic in its $150 million Series B financing.
- Represented BrightPlan in its Series B financing and note financing.
- Represented Percipient.ai in its Series C-1 financing.
- Represented Bryj in its Series C financing.
- Represented Axbio in its Series B financing.
- Represented On Your Six Distillery in its Series A financing.
- Represented Smelt Technologies in its Series A financing.
- Represented Megarobo Technologies in its investment of PGenAxy.
- Represented Bryte in its various note financings.
- Represented L-Charge in its Series A financing.
- Represented Project Vesta, PBC in its Series A financing.
- Represented Nova Credit Inc. in its Series B financing.
- Represented Mirvie in its Series A-1 financing.
- Represented Drop Water in its Series A financing.
Select investor representations include:
- Represented Sequoia Capital in its investment in Tim Hortons China.
- Represented Sequoia Capital in its investment in SprintRay.
- Represented Temasek in connection with its Series D investment in BlueVoyant.
- Represented Temasek in connection with its Series D investment in Twin Health.
- Represented Temasek in connection with its Series C3 investment in Provivi.
- Represented Venrock in its Series A investment in Viralogic Therapeutics.
- Represented Venrock in its Series A-3 investment in Candid Care.
- Represented RTW Investments in its Series B investment in Oricell.
- Represented Siemens Financial Services in its Series B-2 financing in 80 Acres.
- Represented Siemens Financial Services in its investment in KORE Power.
- Represented Pangaea Ventures in its Series B investment in Sun Genomics.
- Represented Boyu Capital in connection with its $104 million share purchase in Lifestyles Healthcare.
- Represented Boyu Capital in connection with its $100 million Series F investment in Huolala Global (Lalamove).
- Jointly represented Boyu Capital, Sequoia Capital, Matrix Partners and Wuxi AppTec in its $150 million Series A investment in D3 Bio.
- Represented Boyu Capital in connection with its Series C investment in 2Health Biosciences.
- Represented Boyu Capital in connection with its private equity investment in J&T Express.
- Represented Boyu Capital in connection with its Series B investment in Hongene Biotech.
- Represented Boyu Capital in connection with its private equity investment in Genki Forest.
- Represented Wuxi AppTec in its Series A investment in Simcha Therapeutics.
- Represented Catchlight Capital Partners in its various investments.
M&A and Capital Market Transactions*
- Represented Splunk in its acquisition of TwinWave Security.
- Represented Caption Health in acquisition by GE Healthcare.
- Represented Ji Xing Pharmaceuticals on Acquisition of BIIB131 from Biogen and Strategic Collaborations with TMS.
- Represented SK Growth Opportunities Corporation in $7.3 billion business combination with Webull Corporation.
- Represented GotIt! in its spin-off transaction for its artificial intelligence business.
- Represented Alibaba Group (BABA) in its $25 billion IPO and its listing in the NYSE.
- Represented the Stephen A. Schwarzman Education Foundation in connection with the creation of a $300 million scholarship fund for study at Tsinghua University in Beijing and the creation of Schwarzman College at the University.
- Represented Danone Asia Pte. Ltd. in connection with the formation of joint ventures with Inner Mongolia Mengniu (Group) Co., Ltd. for chilled yoghurt and related products in China.
* Includes matters handled prior to joining Wilson Sonsini.
Select Publications
- Co-author, The Scramble: E-Gaming Legal Year in Review: 2023, Electronic Gaming Group, Wilson Sonsini, March 2024
- Co-author, The Scramble: E-Gaming Legal Year in Review: 2022, Electronic Gaming Group, Wilson Sonsini, March 2023
Select Publications
- Co-author, The Scramble: E-Gaming Legal Year in Review: 2023, Electronic Gaming Group, Wilson Sonsini, March 2024
- Co-author, The Scramble: E-Gaming Legal Year in Review: 2022, Electronic Gaming Group, Wilson Sonsini, March 2023
- Artificial Intelligence and Machine Learning
- Biotech
- Clean Energy
- Climate and Clean Technologies
- Consumer Products and Services
- Corporate
- Data Storage and Cloud
- Digital Health
- Electronic Gaming
- Emerging Companies and Venture Capital
- Mobility
- Software
- Special Purpose Acquisition Companies (SPACs)
- U.S. Expansion
Wilson Sonsini's The Scramble: 2023 Gaming Legal Year in Review provides an overview of the gaming industry and legal highlights from 2023. The report underscores the significant influence of artificial intelligence (AI) in the gaming realm in 2023 and anticipates further substantial impacts. The Scramble also features a collection of EGG’s industry-leading publications from the last year.
- Privacy Policy
- Terms of Use
- Accessibility